Materials for Non-Viral Gene Delivery

▪ Abstract Novel therapeutic strategies can be envisioned based on altering the expression level of target genes involved in cellular processes and disease progression; however, our ability to efficiently manipulate gene expression is limited. Non-viralbased gene therapy provides a relatively safe approach to increase or decrease the expression of a specific gene using DNA or antisense sequences; however, synthetic systems are required to direct plasmids and oligonucleotides to a specific tissue and to enhance cellular uptake and intracellular trafficking. Numerous materials are being developed that interact with DNA to enhance its properties (e.g. stability, charge density) and thus direct its biodistribution and facilitate cellular interactions. The development of synthetic delivery systems to manipulate gene expression efficiently is a powerful tool that will ultimately lead to novel therapeutic strategies for the treatment of numerous disorders.

[1]  J. Hagstrom,et al.  Plasmid DNA entry into postmitotic nuclei of primary rat myotubes. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[2]  F J Schoen,et al.  Founder's Award, 25th Annual Meeting of the Society for Biomaterials, perspectives. Providence, RI, April 28-May 2, 1999. Tissue heart valves: current challenges and future research perspectives. , 1999, Journal of biomedical materials research.

[3]  C. Bennett,et al.  Antisense oligonucleotides: is the glass half full or half empty? , 1998, Biochemical pharmacology.

[4]  J. Wolff,et al.  The efficient expression of intravascularly delivered DNA in rat muscle , 1998, Gene Therapy.

[5]  Mönkkönen,et al.  Lipid fusion in oligonucleotide and gene delivery with cationic lipids. , 1998, Advanced drug delivery reviews.

[6]  J. S. Choi,et al.  Poly(ethylene glycol)-block-poly(L-lysine) dendrimer: novel linear polymer/dendrimer block copolymer forming a spherical water-soluble polyionic complex with DNA. , 1999, Bioconjugate chemistry.

[7]  Leaf Huang,et al.  Potentiation of cationic liposome-mediated gene delivery by polycations. , 1996, Biochemistry.

[8]  S. Goldstein,et al.  Gene therapy for tissue repair and regeneration. , 1998, Advanced drug delivery reviews.

[9]  J. Gariépy,et al.  Peptide-based intracellular shuttle able to facilitate gene transfer in mammalian cells. , 1999, Bioconjugate chemistry.

[10]  F. Szoka,et al.  Synthesis and characterization of long chain alkyl acyl carnitine esters. Potentially biodegradable cationic lipids for use in gene delivery. , 1998, Journal of medicinal chemistry.

[11]  G. Kwon,et al.  Encapsulation of plasmid DNA in biodegradable poly(D, L-lactic-co-glycolic acid) microspheres as a novel approach for immunogene delivery. , 1999, Journal of controlled release : official journal of the Controlled Release Society.

[12]  F. Szoka,et al.  Physicochemical characterization and purification of cationic lipoplexes. , 1999, Biophysical journal.

[13]  W. Hennink,et al.  2-(Dimethylamino)ethyl methacrylate based (co)polymers as gene transfer agents. , 1998, Journal of controlled release : official journal of the Controlled Release Society.

[14]  J. Wolff,et al.  Hypothesis: naked plasmid DNA is taken up by cells in vivo by a receptor‐mediated process , 2000, The journal of gene medicine.

[15]  F. Cohen,et al.  A combinatorial approach to the discovery of efficient cationic peptoid reagents for gene delivery. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[16]  D. Scherman,et al.  A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[17]  C H Wu,et al.  Receptor-mediated in vitro gene transformation by a soluble DNA carrier system. , 1987, The Journal of biological chemistry.

[18]  A. Miller,et al.  An RGD-oligolysine peptide: a prototype construct for integrin-mediated gene delivery. , 1998, Human gene therapy.

[19]  D J Mooney,et al.  Open pore biodegradable matrices formed with gas foaming. , 1998, Journal of biomedical materials research.

[20]  J. Behr,et al.  Targeted gene transfer into hepatoma cells with lipopolyamine-condensed DNA particles presenting galactose ligands: a stage toward artificial viruses. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[21]  L. Smith,et al.  A physicochemical approach for predicting the effectiveness of peptide-based gene delivery systems for use in plasmid-based gene therapy. , 1998, Biophysical journal.

[22]  Y. Takakura,et al.  Extravasation of macromolecules. , 1998, Advanced drug delivery reviews.

[23]  B. Stripp,et al.  Utilization of modified surfactant-associated protein B for delivery of DNA to airway cells in culture. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[24]  J. Hagstrom,et al.  pH-sensitive, cationic liposomes: A new synthetic virus-like vector , 1996, Nature Biotechnology.

[25]  J. Bonadio,et al.  Stability of peptide-condensed plasmid DNA formulations. , 1998, Journal of pharmaceutical sciences.

[26]  R. Macdonald,et al.  Factors governing the assembly of cationic phospholipid-DNA complexes. , 2000, Biophysical journal.

[27]  D. Putnam,et al.  PLGA microspheres containing plasmid DNA: preservation of supercoiled DNA via cryopreparation and carbohydrate stabilization. , 1999, Journal of pharmaceutical sciences.

[28]  D A Jans,et al.  Signals mediating nuclear targeting and their regulation: Application in drug delivery , 1998, Medicinal research reviews.

[29]  K. Zatloukal,et al.  Gene transfer into hepatocytes using asialoglycoprotein receptor mediated endocytosis of DNA complexed with an artificial tetra-antennary galactose ligand. , 1992, Bioconjugate chemistry.

[30]  R. Podgornik,et al.  The Structure of DNA−Liposome Complexes , 1997 .

[31]  T. Anchordoquy,et al.  Maintenance of transfection rates and physical characterization of lipid/DNA complexes after freeze-drying and rehydration. , 1997, Archives of biochemistry and biophysics.

[32]  Y. Capan,et al.  Influence of formulation parameters on the characteristics of poly(D, L-lactide-co-glycolide) microspheres containing poly(L-lysine) complexed plasmid DNA. , 1999, Journal of controlled release : official journal of the Controlled Release Society.

[33]  L. Vitiello,et al.  Condensation of plasmid DNA with polylysine improves liposome-mediated gene transfer into established and primary muscle cells. , 1996, Gene therapy.

[34]  R. Ghirlando,et al.  Mode of formation and structural features of DNA-cationic liposome complexes used for transfection. , 1993, Biochemistry.

[35]  A. Rolland,et al.  Controllable gene therapy pharmaceutics of non-viral gene delivery systems , 1996 .

[36]  N A Peppas,et al.  New challenges in biomaterials. , 1994, Science.

[37]  F. Szoka,et al.  Design, synthesis, and characterization of a cationic peptide that binds to nucleic acids and permeabilizes bilayers. , 1997, Biochemistry.

[38]  J. Behr,et al.  Gene delivery: a single nuclear localization signal peptide is sufficient to carry DNA to the cell nucleus. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[39]  E. Canning,et al.  A triploblast origin for Myxozoa? , 1998, Nature.

[40]  H. Hofland,et al.  Formation of stable cationic lipid/DNA complexes for gene transfer. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[41]  P. Ross,et al.  Lipoplex size is a major determinant of in vitro lipofection efficiency , 1999, Gene Therapy.

[42]  S. Simões,et al.  Gene delivery mediated by cationic liposomes: from biophysical aspects to enhancement of transfection. , 1999, Molecular membrane biology.

[43]  F. Szoka,et al.  Effect of serum components on the physico-chemical properties of cationic lipid/oligonucleotide complexes and on their interactions with cells. , 1998, Biochimica et biophysica acta.

[44]  R. Kumar,et al.  Enhanced gene delivery and mechanism studies with a novel series of cationic lipid formulations. , 1994, The Journal of biological chemistry.

[45]  A. Mikos,et al.  Tracking the intracellular path of poly(ethylenimine)/DNA complexes for gene delivery. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[46]  D. Scherman,et al.  Formulations which increase the size of lipoplexes prevent serum‐associated inhibition of transfection , 2000, The journal of gene medicine.

[47]  R. Langer,et al.  Drug delivery and targeting. , 1998, Nature.

[48]  F. Szoka,et al.  Synthesis and characterization of a trigalactosylated bisacridine compound to target DNA to hepatocytes. , 1993, Bioconjugate chemistry.

[49]  J. Baker,et al.  Efficient transfer of genes into murine cardiac grafts by Starburst polyamidoamine dendrimers. , 1998, Human gene therapy.

[50]  M. Monsigny,et al.  Specific gene transfer mediated by lactosylated poly-L-lysine into hepatoma cells. , 1993, Nucleic acids research.

[51]  Joachim O. Rädler,et al.  Structure of DNA-Cationic Liposome Complexes: DNA Intercalation in Multilamellar Membranes in Distinct Interhelical Packing Regimes , 1997, Science.

[52]  J. Pachence,et al.  Collagen-based devices for soft tissue repair. , 1996, Journal of biomedical materials research.

[53]  E. Eriksson,et al.  In vivo transfer and expression of a human epidermal growth factor gene accelerates wound repair. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[54]  L. Véron,et al.  Synthesis of polyallylamine derivatives and their use as gene transfer vectors in vitro. , 1999, Bioconjugate chemistry.

[55]  S. Diamond,et al.  Nonclassical Nuclear Localization Signal Provides for High Efficiency, Nonviral Gene Transfer to Nondividing Endothelium , 1999, Nature Biotechnology.

[56]  M. Monsigny,et al.  Enhanced biological activity of antisense oligonucleotides complexed with glycosylated poly-L-lysine. , 1996, Molecular pharmacology.

[57]  J. Northrop,et al.  Lipofection: a highly efficient, lipid-mediated DNA-transfection procedure. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[58]  S. Goldstein,et al.  Stimulation of new bone formation by direct transfer of osteogenic plasmid genes. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[59]  C. Dick,et al.  Characterization of Polyethylenimine , 1970 .

[60]  A Oosterhof,et al.  Preparation and characterization of porous crosslinked collagenous matrices containing bioavailable chondroitin sulphate. , 1999, Biomaterials.

[61]  Mark Saltzman W,et al.  Materials for protein delivery in tissue engineering. , 1998, Advanced drug delivery reviews.

[62]  S. Kong,et al.  Analysis of Cationic Liposome-mediated Interactions of Plasmid DNA with Murine and Human Melanoma Cells in Vitro * , 1997, The Journal of Biological Chemistry.

[63]  Jeffrey Bonadio,et al.  Localized, direct plasmid gene delivery in vivo: prolonged therapy results in reproducible tissue regeneration , 1999, Nature Medicine.

[64]  G. Karlsson,et al.  Complexes between cationic liposomes and DNA visualized by cryo-TEM. , 1995, Biochimica et biophysica acta.

[65]  John W. Park,et al.  Cationic Liposomes Coated with Polyethylene Glycol As Carriers for Oligonucleotides* , 1998, The Journal of Biological Chemistry.

[66]  V. Zurawski,et al.  Cellular localization of the folate receptor: potential role in drug toxicity and folate homeostasis. , 1992, Cancer research.

[67]  O. Zelphati,et al.  Analytical methods for the characterization of cationic lipid-nucleic acid complexes. , 1998, Human gene therapy.

[68]  J. Broach,et al.  New assay technologies for high-throughput screening. , 1998, Current opinion in chemical biology.

[69]  M. Monsigny,et al.  Efficient gene transfer by histidylated polylysine/pDNA complexes. , 1999, Bioconjugate chemistry.

[70]  R. Scheule,et al.  Detailed analysis of structures and formulations of cationic lipids for efficient gene transfer to the lung. , 1996, Human gene therapy.

[71]  Mark E. Davis,et al.  New class of polymers for the delivery of macromolecular therapeutics. , 1999 .

[72]  C. Plank,et al.  Application of membrane-active peptides for drug and gene delivery across cellular membranes. , 1998, Advanced drug delivery reviews.

[73]  T. Ochiya,et al.  New delivery system for plasmid DNA in vivo using atelocollagen as a carrier material: the Minipellet , 1999, Nature Medicine.

[74]  F. Szoka,et al.  Mechanism of DNA release from cationic liposome/DNA complexes used in cell transfection. , 1996, Biochemistry.

[75]  L. M. Sanders,et al.  Prolonged controlled-release of nafarelin, a luteinizing hormone-releasing hormone analogue, from biodegradable polymeric implants: influence of composition and molecular weight of polymer. , 1986, Journal of pharmaceutical sciences.

[76]  M R Fannon,et al.  Gene expression in normal and disease states--identification of therapeutic targets. , 1996, Trends in biotechnology.

[77]  I. Date,et al.  In vivo gene transfer into the adult mammalian central nervous system by continuous injection of plasmid DNA–cationic liposome complex , 1998, Brain Research.

[78]  M. Cotten,et al.  Adenovirus enhancement of transferrin-polylysine-mediated gene delivery. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[79]  David J. Mooney,et al.  DNA delivery from polymer matrices for tissue engineering , 1999, Nature Biotechnology.

[80]  Todd D. Giorgio,et al.  Transfection by Cationic Liposomes Using Simultaneous Single Cell Measurements of Plasmid Delivery and Transgene Expression* , 1997, The Journal of Biological Chemistry.

[81]  D. Scherman,et al.  Novel non-viral vectors for gene delivery: synthesis of a second-generation library of mono-functionalized poly-(guanidinium)amines and their introduction into cationic lipids. , 1998, Biotechnology and bioengineering.

[82]  K. Anseth,et al.  Crosslinked polyanhydrides for use in orthopedic applications: degradation behavior and mechanics. , 1999, Journal of biomedical materials research.

[83]  M. Cotten,et al.  Transferrin-polycation conjugates as carriers for DNA uptake into cells. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[84]  H. O'brodovich,et al.  Metabolic instability of plasmid DNA in the cytosol: a potential barrier to gene transfer , 1999, Gene Therapy.

[85]  L. Smith,et al.  Hepatic gene therapy: adenovirus enhancement of receptor-mediated gene delivery and expression in primary hepatocytes. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[86]  M Schena,et al.  Microarrays: biotechnology's discovery platform for functional genomics. , 1998, Trends in biotechnology.

[87]  Leaf Huang,et al.  New structures in complex formation between DNA and cationic liposomes visualized by freeze—fracture electron microscopy , 1994, FEBS letters.

[88]  D A Lauffenburger,et al.  Optimization of Cell Surface Binding Enhances Efficiency and Specificity of Molecular Conjugate Gene Delivery* , 1998, The Journal of Biological Chemistry.

[89]  F. Szoka,et al.  Lipoplex-mediated gene delivery to the lung occurs within 60 minutes of intravenous administration. , 1999, Human gene therapy.

[90]  T Salditt,et al.  An inverted hexagonal phase of cationic liposome-DNA complexes related to DNA release and delivery. , 1998, Science.

[91]  F. Szoka,et al.  Characterization of plasmid DNA transfer into mouse skeletal muscle: evaluation of uptake mechanism, expression and secretion of gene products into blood. , 1996, Gene therapy.

[92]  L. Barrett,et al.  Factors affecting blood clearance and in vivo distribution of polyelectrolyte complexes for gene delivery , 1999, Gene Therapy.

[93]  William A. Goddard,et al.  Starburst Dendrimers: Molecular‐Level Control of Size, Shape, Surface Chemistry, Topology, and Flexibility from Atoms to Macroscopic Matter , 1990 .

[94]  Joseph Zabner,et al.  Cellular and Molecular Barriers to Gene Transfer by a Cationic Lipid (*) , 1995, The Journal of Biological Chemistry.

[95]  R. Macdonald,et al.  O-ethylphosphatidylcholine: A metabolizable cationic phospholipid which is a serum-compatible DNA transfection agent. , 1999, Journal of pharmaceutical sciences.

[96]  W. Hennink,et al.  Structure-activity relationships of water-soluble cationic methacrylate/methacrylamide polymers for nonviral gene delivery. , 1999, Bioconjugate chemistry.

[97]  D. Putnam,et al.  Design of imidazole-containing endosomolytic biopolymers for gene delivery. , 2000, Biotechnology and bioengineering.

[98]  A. Mikos,et al.  Inhibition of smooth muscle cell growth in vitro by an antisense oligodeoxynucleotide released from poly(DL-lactic-co-glycolic acid) microparticles. , 1997, Journal of biomedical materials research.

[99]  David A. Williams Retroviral‐Fibronectin Interactions in Transduction of Mammalian Cells , 1999, Annals of the New York Academy of Sciences.

[100]  P. Cullis,et al.  Structural and fusogenic properties of cationic liposomes in the presence of plasmid DNA. , 1997, Biophysical journal.

[101]  F. Szoka,et al.  Polyamidoamine cascade polymers mediate efficient transfection of cells in culture. , 1993, Bioconjugate chemistry.

[102]  J. Clegg,et al.  Poly(DL-lactide-co-glycolide)-encapsulated plasmid DNA elicits systemic and mucosal antibody responses to encoded protein after oral administration. , 1997, Vaccine.

[103]  N. Templeton,et al.  New directions in liposome gene delivery , 1999, Molecular biotechnology.

[104]  Bowie,et al.  Development of engineered cells for implantation in gene therapy. , 1998, Advanced drug delivery reviews.

[105]  P. Davis,et al.  Chain Length of the Polylysine in Receptor-targeted Gene Transfer Complexes Affects Duration of Reporter Gene Expression Both in Vitro and in Vivo * , 1999, The Journal of Biological Chemistry.

[106]  M. Bassik,et al.  DNA vector chemistry: The covalent attachment of signal peptides to plasmid DNA , 1998, Nature Biotechnology.

[107]  K. Yip,et al.  Controlled release of plasmid DNA , 1997 .

[108]  W. Mark Saltzman,et al.  Enhancement of transfection by physical concentration of DNA at the cell surface , 2000, Nature Biotechnology.

[109]  P. Khavari,et al.  Direct cutaneous gene delivery in a human genetic skin disease. , 1997, Human gene therapy.

[110]  D. Scherman,et al.  Synthesis, activity, and structure--activity relationship studies of novel cationic lipids for DNA transfer. , 1998, Journal of medicinal chemistry.

[111]  L. Pietrasanta,et al.  DNA toroids: stages in condensation. , 1999, Biochemistry.

[112]  M. Monsigny,et al.  Gene transfer by DNA/glycosylated polylysine complexes into human blood monocyte-derived macrophages. , 1996, Human gene therapy.

[113]  P. Glazer,et al.  Triplex DNA: fundamentals, advances, and potential applications for gene therapy , 1997, Journal of Molecular Medicine.

[114]  Leaf Huang,et al.  Folate-targeted, Anionic Liposome-entrapped Polylysine-condensed DNA for Tumor Cell-specific Gene Transfer (*) , 1996, The Journal of Biological Chemistry.

[115]  L. Smith,et al.  Pharmaceutical perspectives of nonviral gene therapy. , 1999, Advances in genetics.

[116]  R. Crooke,et al.  Structural requirements for cationic lipid mediated phosphorothioate oligonucleotides delivery to cells in culture. , 1998, Journal of drug targeting.

[117]  D. Friend,et al.  Endocytosis and intracellular processing accompanying transfection mediated by cationic liposomes. , 1996, Biochimica et biophysica acta.

[118]  P. Low,et al.  Delivery of macromolecules into living cells: a method that exploits folate receptor endocytosis. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[119]  L. Seymour,et al.  Key issues in non-viral gene delivery. , 1998, Advanced drug delivery reviews.

[120]  J. Baker,et al.  The interaction of plasmid DNA with polyamidoamine dendrimers: mechanism of complex formation and analysis of alterations induced in nuclease sensitivity and transcriptional activity of the complexed DNA. , 1997, Biochimica et biophysica acta.

[121]  D. Papahadjopoulos,et al.  Stabilization of cationic liposome‐plasmid DNA complexes by polyamines and poly(ethylene glycol)‐phospholipid conjugates for efficient in vivo gene delivery , 1997, FEBS letters.

[122]  C. K. Chan,et al.  Enhancement of polylysine-mediated transferrinfection by nuclear localization sequences: polylysine does not function as a nuclear localization sequence. , 1999, Human gene therapy.

[123]  Donald E. Chickering,et al.  Biologically erodable microspheres as potential oral drug delivery systems , 1997, Nature.

[124]  G. Levi,et al.  Size, diffusibility and transfection performance of linear PEI/DNA complexes in the mouse central nervous system , 1998, Gene Therapy.

[125]  M. Hedley,et al.  Microspheres containing plasmid-encoded antigens elicit cytotoxic T-cell responses , 1998, Nature Medicine.

[126]  David J. Mooney,et al.  Synthesis and Properties of Biodegradable Polymers Used as Synthetic Matrices for Tissue Engineering , 1997 .

[127]  L. Smith,et al.  Folate receptor mediated DNA delivery into tumor cells: potosomal disruption results in enhanced gene expression. , 1994, Gene therapy.

[128]  P. Cullis,et al.  Stabilized plasmid-lipid particles: factors influencing plasmid entrapment and transfection properties. , 1999, Biochimica et biophysica acta.

[129]  F R Haselton,et al.  Mitosis enhances transgene expression of plasmid delivered by cationic liposomes. , 1999, Biochimica et biophysica acta.

[130]  Robijn Bruinsma,et al.  Electrostatics of DNA-cationic lipid complexes: isoelectric instability , 1998 .